RxDoctor Payments DataLook up a doctor →

Daniel Rohweder, DO

Family Medicine · Colorado Springs, CONPI 1508958729

Payments from drug & device makers

$20,891in general payments, 2019–2025

Across 1,112 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • AstraZeneca$1K
  • Amgen$958
  • Lilly USA, LLC$944
  • Johnson & Johnson$908
  • Novo Nordisk$806
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)191$5,358
AstraZeneca(2 entities)72$1,421
Amgen(2 entities)59$958
Lilly USA, LLC75$944
Johnson & Johnson54$908
Novo Nordisk57$806
Boehringer Ingelheim46$753
GSK47$719
Pfizer63$698
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC47$645
Otsuka America Pharmaceutical, Inc.31$631
Supernus Pharmaceuticals, Inc.4$525
Gilead16$393
Merck24$350
Esperion Therapeutics, Inc.18$332
Viiv Healthcare Company18$312
Novartis16$280
Bayer15$270
Biohaven Pharmaceuticals, Inc.16$264
Amarin Pharma, Inc.16$250
Eisai Inc.17$247
Biohaven Pharmaceutical Holding Company Ltd.18$245
Adlon Therapeutics L.p.14$226
Sanofi-aventis U.S. LLC14$209
Corium, LLC10$208
Astellas Pharma US Inc11$207
Takeda Pharmaceuticals U.S.A., Inc.9$165
Kowa Pharmaceuticals America, Inc.10$163
Amneal Pharmaceuticals LLC9$136
Inspire Medical Systems, Inc.1$134
Medtronic3$134
Optinose US, Inc.6$126
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$114
Boston Scientific5$112
Idorsia Pharmaceuticals US Inc6$112
Ironshore Pharmaceuticals Inc.2$96
E.r. Squibb & Sons, L.L.C.5$92
Shire North American Group Inc7$89
Seqirus USA Inc4$75
Nestle Healthcare Nutrition Inc.4$70
Abbott3$58
Kaleo, Inc.4$55
Genentech USA, Inc.3$54
Paratek Pharmaceuticals, Inc.3$54
Exact Sciences3$54
Teva Pharmaceuticals USA, Inc.3$53
Dexcom, Inc.3$50
Hologic Sales And Service, LLC4$50
Mannkind Corporation3$45
Phathom Pharmaceuticals, Inc.2$44
Vertical Pharmaceuticals, LLC2$41
Electromed, Inc.1$39
Jazz Pharmaceuticals Inc.2$37
ANI Pharmaceuticals, Inc.2$36
Valeritas, Inc.2$35
Lundbeck LLC2$33
Noven Therapeutics, LLC2$32
IBSA Pharma Inc.2$30
Lucid Diagnostics Inc.2$28
Abiomed1$26

How this compares

$20,891 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$109,766
Medicare patients
316
Services billed
1,396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Colorado Springs

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →